A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT03160898 · COMPLETED
Trial details
- NCT number
- NCT03160898
- Sponsor
- Cytokinetics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2019-03-07
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.